Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis

Diabetes Research and Clinical Practice

Volumn 90, Issue 1, 2010, Pages 22-25

  Sobngwi, E ^a,b   Ashuntantang, G ^a   Ndounia, E ^a   Dehayem, M ^a   Azabji Kenfack, M ^a   Kaze, F ^a   Balti, E ^a   Mbanya, J C ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

CGMS; End stage renal disease; Haemodialysis; Interstitial glucose; Monitoring

Indexed keywords

DIALYSIS FLUID; GLUCOSE; UREA;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CAPILLARY BLOOD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPERTENSION; INTERSTITIUM; KIDNEY FAILURE; LONG TERM CARE; MAINTENANCE THERAPY; MALE; RECORDER; TOTAL BODY WATER; TREATMENT DURATION; TREND STUDY; UREA BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; KIDNEY FAILURE, CHRONIC; MALE; MONITORING, AMBULATORY; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956184371     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.06.001     Document Type: Article

References (10)

1. Schmitz O., Orskov L., Lund S., Møller N., Christiansen J.S., Orskov H. Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children. J Pediatr Endocrinol 1993, 6(1):53-59.
2. Siew E.D., Pupim L.B., Majchrzak K.M., Shintani A., Flakoll P.J., Ikizler T.A. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 2007, 71(2):146-152.
3. Schmitz O. Glucose metabolism in non-diabetic and insulin-dependent diabetic subjects with end-stage renal failure. Dan Med Bull 1991, 38(1):36-52.
4. Jackson M.A., Holland M.R., Nicholas J., Lodwick R., Forster D., Macdonald I.A. Hemodialysis-induced hypoglycemia in diabetic patients. Clin Nephrol 2000, 54(1):30-34.
5. Takahashi A., Kubota T., Shibahara N., Terasaki J., Kagitani M., Ueda H., et al. The mechanism of hypoglycemia caused by hemodialysis. Clin Nephrol 2004, 62(5):362-368.
6. Burmeister J.E., Scapini A., da Rosa Miltersteiner D., da Costa M.G., Campos B.M. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis. Nephrol Dial Transplant 2007, 22(4):1184-1189.
7. Pitkänen E., Koivula T. Continuous blood glucose monitoring and characteristics of diabetes in patients on maintenance haemodialysis treatment. Scand J Urol Nephrol 1979, 13(3):309-312.
8. Javid P.J., Halwick D.R., Betit P., Thompson J.E., Long K., Zhang Y., et al. The first use of live continuous glucose monitoring in patients on extracorporeal life support. Diabetes Technol Ther 2005, 7(3):431-439.
9. Riveline J.P., Teynie J., Belmouaz S., Franc S., Dardari D., Bauwens M., et al. Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant 2009, 24(September (9)):2866-2871.
10. ® continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000, 2(1):49-56.